[Comparative study of six quinolone antibacterials (author's transl)].
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000652:urine; D001419:Bacteria / Q000187:drug effects*; D004148:Dioxolanes / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004352:Drug Resistance, Microbial; D006801:Humans; D009268:Nalidixic Acid / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology; D010093:Oxolinic Acid / Q000494:pharmacology; D011724:Pyridazines / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D011807:Quinolizines / Q000494:pharmacology; D013045:Species Specificity
D000900:Anti-Bacterial Agents; D004148:Dioxolanes; D009539:Nicotinic Acids; D011724:Pyridazines; D011759:Pyrrolidines; D011807:Quinolizines; D009268:Nalidixic Acid; D010093:Oxolinic Acid
Activité antibactérienne comparée de six quinolones.